Schoenbeck, Kelly L. http://orcid.org/0000-0002-2408-6836
Flynn, Kathryn E. http://orcid.org/0000-0002-4427-3583
Article History
Accepted: 29 August 2021
First Online: 14 October 2021
Declarations
:
: KE Flynn receives grants from the NIH and Novartis, and performs consulting for ReFocus and Inhibikase. KL Schoenbeck receives research funding from the American Society of Hematology.
: This article does not contain any studies with human or animal subjects performed by any of the authors.